Document is current
Any future updates will be listed below
-
Authors
Tschenett, Hannah
Vafai-Tabrizi, Florian
Zwick, Ralf Harun
Valipour, Arschang
Funk, Georg-Christian
Nater, Urs M.
-
Funding
Funding for this research was provided by:
University of Vienna
- License Information
-
More Information
Article History
Received: 3 October 2024
Accepted: 16 April 2025
First Online: 26 May 2025
Declarations
:
: The study was in accordance with the Declaration of Helsinki, approved by the city of Vienna ethics review board (serial number: EK 20–177 VK), and preregistered at ClinicalTrials.gov (identifier: NCT04769505). All participants provided written informed consent at baseline.
: All participants provided consent for publication of their de-identified data.
: HT was employed as project assistant by the KLI and received lecture fees by Chiesi. GCF and AV are co-heads of the KLI. GCF received lecture fees by AstraZeneca, Boehringer Ingelheim, Chiesi, and Menarini Pharma. FVT received lecture fees by AstraZeneca, Chiesi, and Menarini Pharma.
